eli lilly stock retatrutide Receives Price Target Boost From Bank of America on Dominant Obesity Drug Outlook Eli Lilly's Retatrutide Clears Two

Over-the-counter (OTC) weight-loss medications Theres only one over-the-counter medication for weight loss thats been approved by the FDA, and thats Alli, a brand name of the drug orlistat

The US market is also witnessing a pivotal affordability shift

Current 2026 approved GLP-1 RA medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)

While many women experience significant weight loss and improved blood sugar control, its essential to consider the reported adverse events, which are generally mild to moderate but require monitoring

Semaglutide A synthetic GLP-1 receptor agonist studied for glucose regulation, insulin secretion, and metabolic function